Clinical Trial Update: Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 study update on DCVAC for localized prostate cancer discusses allowing a second treatment cycle; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DCVAC (dendritic cell vaccine DCVAC/PCa)

Snippet

Sponsor: SOTIO a.s. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED